Exane Derivatives’s Somnigroup International SGI Stock Holding History

Exane Derivatives’s Portfolio SGI Stock Details SGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4	Closed	-$53	–	655
2017 Q2	$53	Hold	4	–	–	﹤0.01%	585
2017 Q1	$46	Hold	4	–	–	﹤0.01%	520
2016 Q4	$68	Hold	4	–	–	﹤0.01%	563
2016 Q3	$57	Hold	4	–	–	﹤0.01%	557
2016 Q2	$55	Sell	4 -4	-50%	-$59	﹤0.01%	486
2016 Q1	$122	Sell	8 -84	-91%	-$1.24K	﹤0.01%	519
2015 Q4	$1.62K	Hold	92	–	–	﹤0.01%	384
2015 Q3	$1.64K	Sell	92 -4	-4%	-$73	﹤0.01%	404
2015 Q2	$1.58K	Sell	96 -4	-4%	-$61	﹤0.01%	425
2015 Q1	$1.44K	Sell	100 -68	-40%	-$942	﹤0.01%	434
2014 Q4	$2.31K	Buy	+168	New	+$2.29K	﹤0.01%	456

Other funds holding SGI

HPM

H. Partners Management New York $191M AUM 5.95% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DIGDR

Dynamo Internacional Gestao de Recursos Rio De Janeiro, Brazil $244M AUM 32.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Echinus Advisors New York $881M AUM 6.76% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return

Exane Derivatives's SGI Position: Q3 2017 in Review

Exane Derivatives sold out of Somnigroup International (SGI) in Q3 2017, closing a stake of 4 shares — an estimated $53 sold.

Exane Derivatives first reported a position in SGI in Q4 2014 and held it in 11 quarters. The position peaked at $2.31K in Q4 2014. 237 funds tracked by Wall St. Rank hold SGI as of Q3 2017.

Exane Derivatives reported no remaining Somnigroup International position as of Q3 2017 after selling out during the quarter.
Exane Derivatives sold 4 Somnigroup International shares in Q3 2017, an estimated $53.
Exane Derivatives first reported a position in Somnigroup International in Q4 2014 and held it in 11 quarters.
Exane Derivatives's Somnigroup International position peaked at $2.31K in Q4 2014.
237 funds tracked by Wall St. Rank held Somnigroup International as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.